Regeneron Pharmaceuticals, Inc. REGN will release earnings results for the second quarter, before the opening bell on Friday, Aug. 1. Analysts expect the Tarrytown, New York -based company to report quarterly earnings at $8.43 per share, down from$11.56 per share in the year-ago period. Regeneron Pharmaceuticals projects to report quarterly revenue at $3.28 billion, compared to$3.55 billion a year earlier, according to data from Benzinga Pro. On July 2, the U.S. Food and Drug Administration (FDA) granted ...